Nevan Charles Elam
Net Worth
Last updated:
What is Nevan Charles Elam net worth?
The estimated net worth of Mr. Nevan Charles Elam is at least $10,149,091 as of 26 Feb 2024. He owns shares worth $49,091 as insider and has received compensation worth at least $10,100,000 in Rezolute, Inc..
What is the salary of Nevan Charles Elam?
Mr. Nevan Charles Elam salary is $1,010,000 per year as Founder, Chief Executive Officer & Director in Rezolute, Inc..
How old is Nevan Charles Elam?
Mr. Nevan Charles Elam is 58 years old, born in 1967.
What stocks does Nevan Charles Elam currently own?
As insider, Mr. Nevan Charles Elam owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | Founder, Chief Executive Officer & Director | 7,817 | $6.28 | $49,091 |
What does Rezolute, Inc. do?
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Nevan Charles Elam insider trading
Rezolute, Inc.
Mr. Nevan Charles Elam has made only one insider trade between 2015-2024, according to the Form 4 filled with the SEC. He purchased 5,000 units of RZLT stock worth $8,400 on 26 Feb 2024.
As of 26 Feb 2024 he still owns at least 7,817 units of RZLT stock.
Rezolute key executives
Rezolute, Inc. executives and other stock owners filed with the SEC:
- Dr. Brian Kenneth Roberts M.D. (50) Senior Vice President & Head of Clinical Devel.
- Mr. Nevan Charles Elam (58) Founder, Chief Executive Officer & Director